U.S. Markets closed

Neurocrine Biosciences, Inc. (NBIX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
94.60+2.67 (+2.90%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.79
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3136.26
52 Week Low 386.02
50-Day Moving Average 399.31
200-Day Moving Average 3100.48

Share Statistics

Avg Vol (3 month) 31.3M
Avg Vol (10 day) 35.13M
Shares Outstanding 594.54M
Implied Shares Outstanding 6N/A
Float 92.66M
% Held by Insiders 11.14%
% Held by Institutions 197.08%
Shares Short (Apr 14, 2021) 46.22M
Short Ratio (Apr 14, 2021) 43.5
Short % of Float (Apr 14, 2021) 46.67%
Short % of Shares Outstanding (Apr 14, 2021) 46.58%
Shares Short (prior month Mar 14, 2021) 44.45M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Dec 28, 1995
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 38.94%
Operating Margin (ttm)31.31%

Management Effectiveness

Return on Assets (ttm)13.46%
Return on Equity (ttm)46.20%

Income Statement

Revenue (ttm)1.05B
Revenue Per Share (ttm)11.23
Quarterly Revenue Growth (yoy)1.60%
Gross Profit (ttm)760.8M
EBITDA 336.1M
Net Income Avi to Common (ttm)407.3M
Diluted EPS (ttm)4.16
Quarterly Earnings Growth (yoy)923.20%

Balance Sheet

Total Cash (mrq)801M
Total Cash Per Share (mrq)8.53
Total Debt (mrq)422.6M
Total Debt/Equity (mrq)37.52
Current Ratio (mrq)5.45
Book Value Per Share (mrq)12.05

Cash Flow Statement

Operating Cash Flow (ttm)228.5M
Levered Free Cash Flow (ttm)268.29M